Академический Документы
Профессиональный Документы
Культура Документы
26. Stack AM, Saladino RA, Thompson C, et al. Failure of prophylactic and 356�62.
therapeutic use of a murine anti�tumor necrosis factor monoclonal 48. Fu�gger R,
Zadrobilek E, Go�tzinger P, et al. Perioperative TNF-alpha and
antibody in Escherichia coli sepsis in the rabbit. Crit Care Med 1995; IL-6
concentrations correlate with septic state, organ function, and
23:1512�8. APACHE II scores in intra-abdominal infection. Eur J Surg 1993;159:
27. Echtenacher B, FalkW,Ma�nnel DN, Krammer PH. Requirement of endog- 525�9.
enous tumor necrosis factor/cachectin for recovery from experimental 49. Patel RT,
Deen KI, Youngs D, Warwick J, Keighley MRB. Interleukin 6
peritonitis. J Immunol 1990;145:3762�6. is a prognostic indicator of outcome in
severe intra-abdominal sepsis.
28. Battafarano RJ, Burd RS, Kurrelmeyer KM, Ratz CA, Dunn DL. Inhibition Br J Surg
1994;81:1306�8.
of splenic macrophage tumor necrosis factor a secretion in vivo by 50. Hamilton G,
Hofbauer S, Hamilton B. Endotoxin, TNF-alpha, interleukinantilipopolysaccharide
monoclonal antibodies. Arch Surg 1994;129: 6 and parameters of the cellular immune
system in patients with intraab179�
86. dominal sepsis. Scand J Infect Dis 1992;24:361�8.
29. Kohler J, Heumann D, Garotta G, et al. IFN-g involvement in the severity 51.
Barriere SL, Lowry SF. An overview of mortality risk prediction in sepsis.
of gram-negative infections in mice. J Immunol 1993;151:916�21. Crit Care Med
1995;23:376�93.
30. Bennion RS, Thompson JE, Baron EJ, Finegold SM. Gangrenous and 52. Wittmann DH,
Bergstein JM, Frantzides C. Calculated empiric antimicroperforated
appendicitis with peritonitis�treatment and bacteriology. bial therapy for mixed
surgical infections. Infection 1991;19(suppl 6):
Clin Ther 1990;12:31�44. S345�50.
31. Weinstein WN, Onderdonk AB, Bartlett JG, Gorbach SL. Experimental 53. Bohnen
JMA, Solomkin JS, Dellinger EP, Bjornson HS, Page CP. Guideintra-
abdominal abscesses in rats: development of an experimental lines for clinical
care: anti-infective agents for intra-abdominal infecmodel.
Infect Immun 1974;10:1250�5. tion: a Surgical Infection Society policy statement.
Arch Surg 1992;
32. Rotstein OD, Pruett TL, Simmons RL. Mechanisms of microbial synergy 127:83�9.
in polymicrobial surgical infections. Rev Infect Dis 1985;7:151�70. 54. Shands JW
Jr. Empiric antibiotic therapy of abdominal sepsis and serious
33. Rotstein OD, Pruett TL, Simmons RL. Microbiologic features and treat-
perioperative infections. Surg Clin North Am 1993;73:291�306.
ment of persistent peritonitis in patients in the intensive care unit. Can 55.
Gerding DN, Olson MM, Johnson S, Peterson LR, Lee JT Jr. Clostridium
J Surg 1986;29:247�50. difficile diarrhea and colonization after treatment with
abdominal infec34.
Sawyer RG, Rosenlof LK, Adams RB, May AK, Spengler MD, Pruett tion regimens
containing clindamycin or metronidazole. Am J Surg
TL. Peritonitis in the 1990s: changing pathogens and changing strategies
1990;159:212�7.
in the critically ill. Am Surgeon 1992;58:82�7. 56. Solomkin JS, Reinhart HH,
Dellinger EP, et al. Results of a randomized
35. Aronoff SC, Olson MM, Gauderer MWL, Jacobs MR, Blumer JL, Izant trial comparing
sequential intravenous/oral treatment with ciprofloxacin
RJ Jr. Pseudomonas aeruginosa as a primary pathogen in children with plus
metronidazole to imipenem/cilastatin for intra-abdominal infecbacterial
peritonitis. J Pediatr Surg 1987;22:861�4. tions. Ann Surg 1996;223:303�15.
36. Yellin AE, Heseltine PNR, Berne TV, et al. The role of Pseudomonas 57. Lennard
ES, Derllinger EP, Wertz MJ, Minshew BH. Implications of
species in patients treated with ampicillin and sulbactam for gangrenous
leukocytosis and fever at conclusion of antibiotic therapy for intraand
perforated appendicitis. Surg Obstet Gynecol 1985;161:303�7. abdominal sepsis. Ann
Surg 1982;195:19�24.
37. Montravers P, Andremont A, Massias L, Carbon C. Investigation of the 58. Stone
HH, Bourneuf AA, Stinson LD. Reliability of criteria for predicting
potential role of Enterococcus faecalis in the pathophysiology of experi-
persistent or recurrent sepsis. Arch Surg 1985;120:17�20.
mental peritonitis. J Infect Dis 1994;169:821�30. 59. Wittmann DH, Schein M, Condon
RE. Management of secondary peritoni38.
Matlow AG, Bohnen JMA, Nohr C, Christou N, Meakins J. Pathogenicity tis. Ann Surg
1996;224:10�8.
of enterococci in a rat model of fecal peritonitis. J Infect Dis 1989;160: 60.
Nathens AB, Rotstein OD. Therapeutic options in peritonitis. Surg Clin
142�5. North Am 1994;74:677�92.
39. Dougherty SH, Flohr AB, Simmons RL. ��Breakthrough�� enterococcal 61. Nespoli
A, Ravizzini C, Trivella M, Segala M. The choice of surgical
septicemia in surgical patients: 19 cases and a review of the literature. procedure
for peritonitis due to colonic perforation. Arch Surg 1993;
Arch Surg 1983;118:232�8. 128:814�8.
40. Jones RN. Gram-positive superinfections following beta-lactam chemo- 62. Polk
HC Jr, Fry DE. Radical peritoneal debridement for established peritotherapy:
the significance of the enterococcus. Infection 1985;13(suppl nitis: the result of
a prospective randomized clinical trial. Ann Surg
1):S81�8. 1980;192:350�5.
41. Barrall DT, Kenney PR, Slotman GJ, Burchard KW. Enterococcal bacter- 63.
Wittmann D, Aprahamian C, Bergstein JM. Etappenlavage: advanced difemia
in surgical patients. Arch Surg 1985;120:57�63. fuse peritonitis managed by planned
multiple laparotomies utilizing
42. Burnett RJ, Haverstock DC, Dellinger EP, et al. Definition of the role zippers,
slide fastener, and Velcrow analogue for temporary abdominal
of Enterococcus in intraabdominal infection: analysis of a prospective closure.
World J Surg 1990;14:218�26.
randomized trial. Surgery 1995;118:716�23. 64. Teichmann W, Wittmann DH, Andreone
PA. Scheduled reoperations
43. Nystro�m P-O, Bax R, Dellinger EP, et al. Proposed definitions for diagno-
(etappenlavage) for diffuse peritonitis. Arch Surg 1986;121:147�52.
sis, severity scoring, stratification, and outcome for trials on intraabdom- 65.
Cuesta MA, Doblas M, Castan�eda L, Bengoechea E. Sequential abdominal
inal infection. World J Surg 1990;14:148�58. reexploration with the zipper
technique. World J Surg 1991;15:74�80.
44. Pacelli F, Doglietto GB, Alfieri S, et al. Prognosis in intra-abdominal 66.
Schein M, Hirshberg A, Hashmonai M. Current surgical management of
infections: multivariate analysis on 604 patients. Arch Surg 1996;131: severe
intraabdominal infection. Surgery 1992;112:489�96.
641�5. 67. Korbet SM, Vonesh EF, Firanek CA. A retrospective assessment of risk
45. Christou NV, Barie PS, Dellinger EP, Waymack JP, Stone HH. Surgical factors for
peritonitis among an urban CAPD population. Perit Dial Int
Infection Society Intra-abdominal Infection Study: prospective evalua-
1993;13:126�31.
tion of management techniques and outcome. Arch Surg 1993;128: 68. Saklayen MG.
CAPD peritonitis: incidence, pathogens, diagnosis, and
193�9. management. Med Clin North Am 1990;74:997�1010.
/ 9c2f$$ju45 05-07-97 17:21:37 cida UC: CID
Downloaded from https://academic.oup.com/cid/article-abstract/24/6/1035/339046 by
guest on 24 October 2018
CID 1997;24 (June) Peritonitis Update 1045
69. Linblad AS, Novak JW, Nolph KD, Stablein DM, Cutler SJ. The 1987 86. Bailie GR,
Eisele G. Continuous ambulatory peritoneal dialysis: a review
USA National CAPD Registry report. Trans Am Soc Artif Intern Organs of its
mechanics, advantages, complications, and areas of controversy.
1988;34:150�6. Ann Pharmacother 1992;26:1409�20.
70. Sheth NK, Bartell CA, Roth DA. In vitro study of bacterial growth in 87. Morse
GD, Farolino DF, Apicella MA, Walshe JJ. Comparative study of
continuous ambulatory peritoneal dialysis fluids. J Clin Microbiol 1986;
intraperitoneal and intravenous vancomycin pharmacokinetics during
23:1096�8. continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemo71.
Marrie TJ, Noble MA, Costerton JW. Examination of the morphology ther
1987;31:173�7.
of bacteria adhering to peritoneal dialysis catheters by scanning and 88. Bennet-
Jones D,Wass V,Mawson P, et al. A comparison of intraperitoneal
transmission electron microscopy. J Clin Microbiol 1983;18:1388�98. and
intravenous/oral antibiotics in CAPD peritonitis. Peritoneal Dialysis
72. Holmes CJ, Evands R. Biofilm and foreign body infection�the signifi- Bulletin
1987;7:31�3.
cance to CAPD associated peritonitis. Peritoneal Dialysis Bulletin 1986; 89. Keane
WF, Everett ED, Fine RN, et al. CAPD-related peritonitis manage6:
168�77. ment and antibiotic therapy recommendations: Travenol Peritonitis
73. Holmes CJ. Peritoneal host defense mechanisms in peritoneal dialysis.
Management Advisory Committee. Peritoneal Dialysis Bulletin 1987;
Kidney Int 1994;46(suppl 48):S58�70. 7:55�62.
74. von Graevenitz A, Amsterdam D. Microbiological aspects of peritonitis 90.
Keller E, Reetze P, Schollmeyer P. Drug therapy in patients undergoing
associated with continuous ambulatory peritoneal dialysis. Clin Micro- continuous
ambulatory peritoneal dialysis: clinical pharmacokinetic
biol Rev 1992;5:36�48. considerations. Clin Pharmacokinet 1990;18:104�17.
75. Krothapalli R, Duffy WB, Lacke C, et al. Pseudomonas peritonitis and 91. Rubin
J, Kirchner K, Walsh D, Green M, Bower J. Fungal peritonitis
continuous ambulatory peritoneal dialysis. Arch Intern Med 1982;142: during
continuous ambulatory peritoneal dialysis: a report of 17 cases.
Am J Kidney Dis 1987;10:361�8.
1862�3.
92. Venning MC, Ford M, Gould GK. Successful treatment of fungal peritoni-
76. Kaczmarski EB, Tooth JA, Anastassiades E, Manos J, Gokal R. Pseudomotis
in CAPD using oral fluconazole [letter]. Nephrol Dial Transplant
nas peritonitis with continuous ambulatory peritoneal dialysis: six year
1990;5:555.
study. Am J Kidney Dis 1988;14:413�7.
93. Nagappan R, Collins JF, Lee WT. Fungal peritonitis in continuous ambula-
77. Eisenberg ES, Leviton I, Soeiro R. Fungal peritonitis in patients receiving
tory peritoneal dialysis�the Auckland experience. Am J Kidney Dis
peritoneal dialysis: experience with eleven patients and review of the
1992;20:492�6.
literature. Rev Infect Dis 1986;8:309�21.
94. Sharma BK, Smith EC, Rodriquez H, Pillay VKG, Gandhi VC, Dunea G.
78. Dressler R, Peters AT, Lynn RI. Pseudomonal and candidal peritonitis as Trial
of oral neomycin during peritoneal dialysis. Am J Med Sci 1971;
a complication of continuous ambulatory peritoneal dialysis in human 262:175�8.
immunodeficiency virus�infected patients. Am J Med 1989;86: 95. Axelrod J, Meyers
BR, Hirschman SZ, Stein R. Prophylaxis with cephalo-
787�90. thin in peritoneal dialysis. Arch Intern Med 1973;132:368�71.
79. Dunmire RB 3d, Breyer JA. Nontuberculous mycobacterial peritonitis 96. Low DE,
Vas SI, Oreopoulos DG, et al. Prophylactic cephalexin ineffective
during continuous ambulatory peritoneal dialysis: case report and review in chronic
ambulatory peritoneal dialysis [letter]. Lancet 1980;2:
of diagnostic and therapeutic strategies. Am J Kidney Dis 1991;18: 753�4.
126�30. 97. Churchill DN, Taylor DW, Vas SI, et al. Peritonitis in continuous
ambula-
80. Hakim A, Hisam N, Reuman PD. Environmental mycobacterial peritonitis tory
peritoneal dialysis patients: a randomized clinical trial of co-trimoxcomplicating
peritoneal dialysis: three cases and review. Clin Infect Dis azole prophylaxis.
Peritoneal Dialysis Bulletin 1988;8:125�8.
1993;16:426�31. 98. Pe�rez-Fonta�n M, Rosales M, Rodri�guez-Carmona A, et al.
Treatment of
81. Band JD, Ward JI, Fraser DW, et al. Peritonitis due to a Mycobacterium
Staphylococcus aureus nasal carriers in CAPD with mupirocin. Adv
chelonei�like organism associated with intermittent chronic peritoneal Peritoneal
Dial 1992;8:242�5.
dialysis. J Infect Dis 1982;145:9�17.
82. Males BM, Walshe JJ, Amsterdam D. Laboratory indices of clinical peritonitis:
total leukocyte count, microscopy, and microbiologic culture of The ��Conflict-of-
Interest Policy�� of the Office of Conperitoneal
dialysis effluent. J Clin Microbiol 1987;25:2367�71. tinuing Medical Education,
UCLA School of Medicine,
83. Digenis GE, Khanna K, Panatlony D. Eosinophilia after implantation of
requires that faculty participating in a CME activity dis- the peritoneal catheter.
Peritoneal Dialysis Bulletin 1982;2:98�9.
84. Gokal R, Ramos JM, Ward MK, Kerr DNS. ��Eosinophilic�� peritonitis close to the
audience any relationship with a pharmaceuin
continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol tical or equipment
company which might pose a poten-
1981;15:328�30. tial, apparent, or real conflict of interest with regard to
85. Ludlam HA, Price TNC, Berry AJ, Phillips I. Laboratory diagnosis of their
contribution to the program. The author reports no
peritonitis in patients on continuous ambulatory peritoneal dialysis. J conflict of
interest.
Clin Microbiol 1988;26:1757�62.
/ 9c2f$$ju45 05-07-97 17:21:37 cida UC: CID
Downloaded from https://academic.oup.com/cid/article-abstract/24/6/1035/339046 by
guest on 24 October 2018